Login
$CAHO
$0.39 +$0.02 (4.0%) Close

Consolidated balance sheets

In USD, except per-share amounts
Q1 FY2027
As of Jun 30, 2026
Q4 FY2026
As of Mar 31, 2026
Q3 FY2026
As of Dec 31, 2025
Q2 FY2026
As of Sep 30, 2025
Q1 FY2026
As of Jun 30, 2025
Q4 FY2025
As of Mar 31, 2025
Q3 FY2025
As of Dec 31, 2024
Q2 FY2025
As of Sep 30, 2024
Q1 FY2025
As of Jun 30, 2024
Q4 FY2024
As of Mar 31, 2024
Q3 FY2024
As of Dec 31, 2023
Q2 FY2024
As of Sep 30, 2023
Q1 FY2024
As of Jun 30, 2023
Q4 FY2023
As of Mar 31, 2023
Q3 FY2023
As of Dec 31, 2022
Q2 FY2023
As of Sep 30, 2022
Q4 FY2022
As of Mar 31, 2022
Q1 FY2023
As of Jun 30, 2022
Q3 FY2022
As of Dec 31, 2021
Q2 FY2022
As of Sep 30, 2021
Cash
Prepaid expense
Accounts receivable and other receivable
Promissory note receivable
Convertible note receivable
Interest receivable
Advance for mineral property interests
Deferred business acquisition cost
Total Current Assets
Software, net
TOTAL ASSETS
Current Liabilities
Accounts payable and accrued liabilities
Accrued interest
Accrued interest payable
Due to related parties
Promissory notes payable
Convertible notes payable
Convertible note payable
Total Current Liabilities
TOTAL LIABILITIES
Stockholders' Equity (Deficit)
Preferred stock: 75,000,000 authorized; $0.00001 par value. No shares issued and outstanding
Common stock shares valued
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive loss
Total Stockholders' Equity (Deficit)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support